Audited Results of Ipca Laboratories Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	6,677.92	6,166.46	5,814.62	5,399.36	5,139.16
Manufacturing Expenses	229.26	253.33	277.21	231.97	201.48
Personnel Expenses	1,479.34	1,336.19	1,193.39	1,089.63	948.84
Selling Expenses	0	0	0	0	0
Administrative Expenses	1,479.24	1,317.70	1,298.08	1,005.86	839.03
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	5,152.89	4,955.08	4,902.77	4,155.82	3,625.58
Operating Profit	1,525.03	1,211.38	911.85	1,243.54	1,513.58
Other Recurring Income	71.29	111.29	111.19	56.13	62.24
Adjusted PBDIT	1,596.32	1,322.67	1,023.04	1,299.67	1,575.82
Financial Expenses	63.04	120.67	43.92	7.21	8.14
Depreciation	251.97	246.48	228.63	204.10	187.72
Other Write offs	0	0	0	0	0
Adjusted PBT	1,281.31	955.52	750.49	1,088.36	1,379.96
Tax Charges	349.01	291.75	244.79	217.42	239.19
Adjusted PAT	932.30	663.77	505.70	870.94	1,140.77
Non Recurring Items	-286.46	-134.75	-2.05	1.04	-0.16
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	650.76	530.41	505.70	870.94	1,140.77
Equity Dividend	101.48	50.74	101.48	101.48	101.48
Preference Dividend	0	0	0	0	0
Retained Earnings	5,501.16	4,956.80	4,478.52	4,086.81	3,316.31

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article